Production (Stage)
Inspire Medical Systems, Inc.
INSP
$143.21
-$2.74-1.88%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -16.02% | 17.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.02% | 17.98% | |||
| Cost of Revenue | -14.67% | 11.08% | |||
| Gross Profit | -16.26% | 19.28% | |||
| SG&A Expenses | 1.96% | 8.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.42% | 10.04% | |||
| Operating Income | -104.66% | 122.68% | |||
| Income Before Tax | -88.65% | 80.24% | |||
| Income Tax Expenses | -17.35% | -22.80% | |||
| Earnings from Continuing Operations | -91.51% | 90.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -91.51% | 90.43% | |||
| EBIT | -104.66% | 122.68% | |||
| EBITDA | -95.46% | 112.53% | |||
| EPS Basic | -91.47% | 90.74% | |||
| Normalized Basic EPS | -88.60% | 80.55% | |||
| EPS Diluted | -91.24% | 90.30% | |||
| Normalized Diluted EPS | -88.48% | 79.55% | |||
| Average Basic Shares Outstanding | -0.42% | -0.17% | |||
| Average Diluted Shares Outstanding | -1.43% | 0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||